Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sangeetha Manokaran"'
Autor:
Ngoc Tam Tran, Cheryl Heiner, Kristina Weber, Michael Weiand, Daniella Wilmot, Jun Xie, Dan Wang, Alexander Brown, Sangeetha Manokaran, Qin Su, Maria L. Zapp, Guangping Gao, Phillip W.L. Tai
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss , Pp 639-651 (2020)
The gene therapy field has been galvanized by two technologies that have revolutionized treating genetic diseases: vectors based on adeno-associated viruses (AAVs), and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas gene-editi
Externí odkaz:
https://doaj.org/article/08e2826eeb014703b9f108d668239025
Autor:
Manish Muhuri, Wei Zhan, Yukiko Maeda, Jia Li, Anoushka Lotun, Jennifer Chen, Katelyn Sylvia, Ishani Dasgupta, Motahareh Arjomandnejad, Thomas Nixon, Allison M. Keeler, Sangeetha Manokaran, Ran He, Qin Su, Phillip W. L. Tai, Guangping Gao
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Recombinant adeno-associated virus (rAAV) platforms hold promise for in vivo gene therapy but are undermined by the undesirable transduction of antigen presenting cells (APCs), which in turn can trigger host immunity towards rAAV-expressed transgene
Externí odkaz:
https://doaj.org/article/01510ca4e9254713881c8470321ee966
Autor:
Suk Namkung, Ngoc Tam Tran, Sangeetha Manokaran, Ran He, Qin Su, Jun Xie, Guangping Gao, Phillip W.L. Tai
Publikováno v:
Hum Gene Ther
Recombinant adeno-associated viruses (rAAVs) are currently the most prominently investigated vector platform for human gene therapy. The rAAV capsid serves as a potent and efficient vehicle for delivering genetic payloads into the host cell, while th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49b4bac82c168e3515a3c09eff53d8ed
https://europepmc.org/articles/PMC9700346/
https://europepmc.org/articles/PMC9700346/
Autor:
Michael Weiand, Phillip W. L. Tai, Daniella Wilmot, Maria L. Zapp, Alexander Brown, Dan Wang, Guangping Gao, Ngoc Tam Tran, Jun Xie, Sangeetha Manokaran, Kristina Weber, Cheryl Heiner, Qin Su
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 639-651 (2020)
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 639-651 (2020)
The gene therapy field has been galvanized by two technologies that have revolutionized treating genetic diseases: vectors based on adeno-associated viruses (AAVs), and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas gene-editi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e819a135385a4cc8751427878ffe42
http://europepmc.org/articles/PMC7397707
http://europepmc.org/articles/PMC7397707